Search results
Scientists Are Studying Weight-Loss Drugs for Way More Than Weight Loss
Time Magazine· 1 hour agoIan Neeland, chair of the American Heart Association’s obesity science committee and an associate...
Is Madrigal Pharmaceuticals Stock a Buy? | The Motley Fool
The Motley Fool· 2 hours agoNot only was Rezdiffra Madrigal's first product on the market, but it is also the first and only...
All About Ozempic and the Next Generation of Obesity Drugs
New York Times· 1 day agoOzempic belongs to a class of medications called GLP-1 receptor agonists, named after a hormone in...
New study focuses on what happens if you stay on weight loss drug Wegovy for years
Good Morning America via Yahoo News· 21 hours agoAmid the growing popularity of drugs used for weight loss like Ozempic, Wegovy, Mounjaro and...
Wegovy, Saxenda study reveals surprising trend for weight loss drugs
USA TODAY via Yahoo News· 6 hours agoPatients...medications. The study found that young adults between 18 and 34 were more likely to ditch the medication before completing...which requires daily injections, was ...
Expert shares what to expect after hip replacement surgery
UPI· 37 minutes agoOlder hip implants were made of metal, but newer ones are largely composed of ceramic and plastic,...
If You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 6 days agoThat's because the Denmark-based company had not yet won U.S. Food and Drug Administration (FDA)...
Roche keeps pace in obesity drug field with early study data
BioPharma Dive via Yahoo Finance· 5 days agoA drug Roche acquired in a buyout of Carmot Therapeutics and that works similarly to Zepbound helped...
Gaps remain between what's known about obesity and how it's being treated
Houston Chronicle· 20 hours agoThe scientific statement from the American Heart Association, published Monday in the journal Circulation, highlights gaps between the growing understanding of the causes and
Medicare Coverage of Wegovy Raises Questions Regarding the Affordability and Accessibility of Novel...
The National Law Review· 6 days agoIn Wegovy’s case, the FDA...cardiovascular death, non-fatal myocardial infarction, or non-fatal...